PICARIELLO, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.343
EU - Europa 663
AS - Asia 205
SA - Sud America 3
AF - Africa 1
Totale 2.215
Nazione #
US - Stati Uniti d'America 1.342
PL - Polonia 130
SE - Svezia 119
IE - Irlanda 118
IT - Italia 102
HK - Hong Kong 72
CN - Cina 56
RU - Federazione Russa 43
DE - Germania 39
UA - Ucraina 36
JO - Giordania 31
SG - Singapore 28
FI - Finlandia 22
GB - Regno Unito 20
BE - Belgio 13
ES - Italia 11
TR - Turchia 10
CH - Svizzera 3
IN - India 3
NL - Olanda 3
BR - Brasile 2
FR - Francia 2
JP - Giappone 2
VN - Vietnam 2
CA - Canada 1
CO - Colombia 1
CZ - Repubblica Ceca 1
IR - Iran 1
RO - Romania 1
SC - Seychelles 1
Totale 2.215
Città #
Fairfield 175
Chandler 172
Warsaw 130
Dublin 117
Ashburn 101
Woodbridge 85
Cambridge 84
Seattle 79
Jacksonville 74
Ann Arbor 70
Houston 69
Wilmington 65
Hong Kong 46
Altamura 29
Lawrence 28
Princeton 27
Boardman 26
Buffalo 26
Florence 22
Beijing 21
Singapore 20
Shanghai 17
Boston 16
Kent 14
Medford 13
Brussels 12
Barcelona 10
West Jordan 10
San Diego 9
Los Angeles 8
New York 8
Bremen 7
Izmir 7
Milan 5
Bari 4
Corigliano Calabro 4
Fontebuona 4
Bern 3
Fuzhou 3
Hillsboro 3
London 3
Norwalk 3
Pune 3
Viareggio 3
Washington 3
Dong Ket 2
Falls Church 2
Farra di Soligo 2
Frankfurt Am Main 2
Laurel 2
Sesto Fiorentino 2
Americana 1
Andover 1
Auburn Hills 1
Baotou 1
Barranquilla 1
Cluj-Napoca 1
Corciano 1
Düsseldorf 1
Groningen 1
Kish 1
Kunming 1
La Spezia 1
Naaldwijk 1
Naples 1
New Bedfont 1
Old Bridge 1
Palma De Mallorca 1
Pasadena 1
Pescara 1
Philadelphia 1
Phoenix 1
Pisa 1
Rui'an 1
Saint Petersburg 1
San Mateo 1
Tokyo 1
Toronto 1
Verona 1
Totale 1.678
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 248
A comparison of methods for the analysis of low abundance proteins in desmoid tumor cells. 122
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 106
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 103
Estrogen metabolism in human colorectal cancer cells. 99
Telomerase repeat amplificationprotocol (TRAP): A new molecular marker for parathyroid carcinoma. 97
A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. 93
Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. 91
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 87
Desmoid Tumors in Familial Adenomatous Polyposis 84
Telomerase repeat amplification protocol (TRAP): A new molecular marker for parathyroid carcinoma. 82
Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: Effect of N-acetylcysteine and curcumin 82
Microencapsulation of human parathyroid cells:an "in vitro" study. 79
Role of N-acetylcysteine and GSH redox system on total and active MMP-2 in intestinal myofibroblasts of Crohn's disease patients 75
Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's disease patients. 72
ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components 69
Desmoid tumours in familial adenomatous polyposis. 64
ESTROGEN SYNTHESIS IN HUMAN COLON CANCER EPITHELIAL CELLS 63
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 59
AZIDOTHYMIDINE INDUCES APOPTOSIS AND INHIBITS CELL GROWTH AND TELOMERASE ACTIVITY OF HUMAN PARATHYROID CANCER IN CELL CULTURE 55
Selective estrogen receptor modulators in desmoid tumours 49
Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's Dsease patients 46
Growth response of colon cancer cell lines to selective estrogen modulators 45
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures. 40
RuvBL1 haploinsufficiency improves mTOR-driven NASH-HCC development in mice 34
Isoforms of the orphan nuclear receptor COUP-TFII differentially modulate pancreatic cancer progression 31
null 31
Role of GSH and oxidative state related on MMP-2 activity in intestinal myofibroblasts of Crohn's disease patients 29
In vitro bioeffects of the antiestrogen LY117018 on desmoid tumor and colon cancer cells. 27
RUVBL1 correlates with chaperones expression in HCC and its activity is required for HSF1-mediated stress response 21
RuvBL1 haploinsufficiency promotes hepatic lipid catabolism hampering NASH-HCC progression in mice 18
T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER 14
Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-HCC development in mice 11
OC.05.6: TARGETING RUVBL1 REDUCES MTOR-DRIVEN NASH-HCC DEVELOPMENT IN MICE 7
Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression in conditional PTEN-KO mice 5
Totale 2.238
Categoria #
all - tutte 7.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020425 0 30 10 41 48 60 51 61 47 26 40 11
2020/2021263 27 18 22 26 6 30 12 26 19 40 16 21
2021/2022186 9 16 7 8 5 12 7 12 8 12 49 41
2022/2023623 42 114 19 65 50 104 75 43 78 2 20 11
2023/2024263 13 22 35 6 15 29 15 58 0 34 18 18
2024/202585 54 31 0 0 0 0 0 0 0 0 0 0
Totale 2.238